Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Greene

Showing results (11-20 of 464) with videos related to

Pageof 47
Sort By:
Cell Cycle (Georgetown, Tex.)|June 27, 2007
FOXP3 actively represses transcription by recruiting the HAT/HDAC complexBin Li, Mark I Greene
Cancers|May 11, 2024
Survivin as a Therapeutic Target for the Treatment of Human CancerQiang Wang, Mark I Greene
Current Opinion in Immunology|October 20, 2010
Regulation of the immune responseMark I Greene, Herman Waldmann
Immunological Reviews|January 1, 1980
Studies on hapten specific T cell immunity and suppressionM I Greene, B Benacerraf
Immunologic Research|February 28, 1998
Structure-based design of immunologically active therapeutic peptidesR Murali, M I Greene
Immunologic Research|January 1, 1992
CD4-CD8+ T-cell receptor-alpha beta+ major histocompatibility complex class-II-specific T-cell clones isolated from aged athymic miceK Yui, M I Greene
Experimental and Molecular Pathology|June 25, 2005
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathwayQiang Wang, Mark I Greene
Archives of Dermatology|October 1, 1979
Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet lightI Greene, A J Cox
The Journal of Clinical Investigation|June 24, 2008
Mechanisms of resistance to ErbB-targeted cancer therapeuticsQiang Wang, Mark I Greene
Pediatric Dermatology|June 1, 1986
Primary cutaneous amyloidosis: identically distributed lesions in identical twinsP E LeBoit, I Greene
Pageof 47

Showing results (11-20 of 464) with videos related to

Sort By:
Pageof 47
Cell Cycle (Georgetown, Tex.)|June 27, 2007
FOXP3 actively represses transcription by recruiting the HAT/HDAC complexBin Li, Mark I Greene
Cancers|May 11, 2024
Survivin as a Therapeutic Target for the Treatment of Human CancerQiang Wang, Mark I Greene
Current Opinion in Immunology|October 20, 2010
Regulation of the immune responseMark I Greene, Herman Waldmann
Immunological Reviews|January 1, 1980
Studies on hapten specific T cell immunity and suppressionM I Greene, B Benacerraf
Immunologic Research|February 28, 1998
Structure-based design of immunologically active therapeutic peptidesR Murali, M I Greene
Immunologic Research|January 1, 1992
CD4-CD8+ T-cell receptor-alpha beta+ major histocompatibility complex class-II-specific T-cell clones isolated from aged athymic miceK Yui, M I Greene
Experimental and Molecular Pathology|June 25, 2005
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathwayQiang Wang, Mark I Greene
Archives of Dermatology|October 1, 1979
Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet lightI Greene, A J Cox
The Journal of Clinical Investigation|June 24, 2008
Mechanisms of resistance to ErbB-targeted cancer therapeuticsQiang Wang, Mark I Greene
Pediatric Dermatology|June 1, 1986
Primary cutaneous amyloidosis: identically distributed lesions in identical twinsP E LeBoit, I Greene
Pageof 47